Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tau in the Pathophysiology of Parkinson’s Disease
Lina Pan, Lanxia Meng, Mingyang He, et al.
Journal of Molecular Neuroscience (2021) Vol. 71, Iss. 11, pp. 2179-2191
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Shared genetic risk loci between Alzheimer’s disease and related dementias, Parkinson’s disease, and amyotrophic lateral sclerosis
Michael Wainberg, Shea J. Andrews, Shreejoy J. Tripathy
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 48
Artificial intelligence–coupled plasmonic infrared sensor for detection of structural protein biomarkers in neurodegenerative diseases
Deepthy Kavungal, Pedro Magalhães, Senthil T. Kumar, et al.
Science Advances (2023) Vol. 9, Iss. 28
Open Access | Times Cited: 47
Nigrostriatal tau pathology in parkinsonism and Parkinson’s disease
Yaping Chu, Warren D. Hirst, Howard J. Federoff, et al.
Brain (2023) Vol. 147, Iss. 2, pp. 444-457
Open Access | Times Cited: 44
The Crucial Role of the Blood–Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications
Sehwan Kim, Un Ju Jung, Sang Ryong Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 386-386
Open Access | Times Cited: 3
Molecular mechanism for the synchronized electrostatic coacervation and co-aggregation of alpha-synuclein and tau
Pablo Gracia, David Polanco, Jorge Tarancón-Díez, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Amyloid-beta and tau protein beyond Alzheimer’s disease
Morteza Abyadeh, Vivek Gupta, João A. Paulo, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 6, pp. 1262-1276
Open Access | Times Cited: 39
Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson’s disease and multiple system atrophy
Hash Brown Taha, Simon Hornung, Suman Dutta, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies
Felix Langerscheidt, Tamara Wied, Mohamed Aghyad Al Kabbani, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 2992-3018
Open Access | Times Cited: 13
Role of Tau Protein in Neurodegenerative Diseases and Development of Its Targeted Drugs: A Literature Review
J Yang, Weijia Zhi, Lifeng Wang
Molecules (2024) Vol. 29, Iss. 12, pp. 2812-2812
Open Access | Times Cited: 13
Combating Parkinson’s Disease with Plant-Derived Polyphenols: Targeting Oxidative Stress and Neuroinflammation
Reem M. Gahtani, Shoaib Shoaib, Umme Hani, et al.
Neurochemistry International (2024) Vol. 178, pp. 105798-105798
Closed Access | Times Cited: 10
Natural polyphenol: Their pathogenesis-targeting therapeutic potential in Alzheimer's disease
Chengu Niu, Miaoxian Dong, Yingcai Niu
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116359-116359
Closed Access | Times Cited: 8
Deciphering the role of neuropeptides as biomarkers for early diagnosis of Parkinson's disease
JS Thakur, Angel Godad
Life Sciences (2025) Vol. 363, pp. 123376-123376
Closed Access | Times Cited: 1
Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer’s and Parkinson’s Diseases
Nidhi Puranik, Minseok Song
Neurology International (2025) Vol. 17, Iss. 2, pp. 26-26
Open Access | Times Cited: 1
Gene regulation by antisense transcription: A focus on neurological and cancer diseases
Sajad Najafi, Shing Cheng Tan, Pourya Raee, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112265-112265
Open Access | Times Cited: 44
Pesticides and the Microbiome-Gut-Brain Axis: Convergent Pathways in the Pathogenesis of Parkinson’s Disease
Kristína Kulcsarová, Corinna Bang, Daniela Berg, et al.
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 7, pp. 1079-1106
Open Access | Times Cited: 20
Identifying actionable druggable targets for breast cancer: Mendelian randomization and population-based analyses
Naiqi Zhang, Yanni Li, Jan Sundquist, et al.
EBioMedicine (2023) Vol. 98, pp. 104859-104859
Open Access | Times Cited: 17
Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease
Jerzy K. Kulski, Shingo Suzuki, Takashi Shiina, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Tau-PET imaging in Parkinson's disease: a systematic review and meta-analysis
Junjiao Zhang, Jianing Jin, Dongning Su, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 14
Neuro-Nutraceutical Polyphenols: How Far Are We?
Maria Teresa Gentile, Iolanda Camerino, Loredana F. Ciarmiello, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 539-539
Open Access | Times Cited: 13
Pathological and physiological functional cross-talks of α-synuclein and tau in the central nervous system
Mingyue Jin, Shengming Wang, Xiaodie Gao, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 4, pp. 855-862
Open Access | Times Cited: 13
Elevated parkinsonism pathological markers in dopaminergic neurons with developmental exposure to atrazine
Han Zhao, Junkai Xie, Shichen Wu, et al.
The Science of The Total Environment (2023) Vol. 908, pp. 168307-168307
Open Access | Times Cited: 13
Advancements in the study of synaptic plasticity and mitochondrial autophagy relationship
Yousong Zhu, Qinlong Hui, Zheng Zhang, et al.
Journal of Neuroscience Research (2024) Vol. 102, Iss. 2
Closed Access | Times Cited: 5
Omega‐3 polyunsaturated fatty acids and Parkinson's disease: A systematic review of animal studies
Barbara da Silva Alves, Lúcia Emanueli Schimith, André Brito da Cunha, et al.
Journal of Neurochemistry (2024) Vol. 168, Iss. 8, pp. 1655-1683
Open Access | Times Cited: 5
Rosmarinic Acid Attenuates Rotenone-Induced Neurotoxicity in SH-SY5Y Parkinson’s Disease Cell Model through Abl Inhibition
Han Xiao, Bing Han, Yue Zhao, et al.
Nutrients (2022) Vol. 14, Iss. 17, pp. 3508-3508
Open Access | Times Cited: 20
α-Synuclein seeding activity in duodenum biopsies from Parkinson’s disease patients
Sarah Vascellari, Christina D. Orrú, Bradley R. Groveman, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 6, pp. e1011456-e1011456
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top